ChEMBL

There is, what looks like, an excellent meeting in London, full details are on the SMR website. I hope I feel better by then.

SMR Award Meeting: Recent Disclosures of Clinical Candidates 10th December 2009  National Heart & Lung Institute, Kensington, London
Programme:
09.30	Registration and coffee
10.00	SMR Award lecture: The Discovery and development of Januvia™, Dr. Ann Weber, Merck (Introduction by - Rob Williams, Cancer Research UK)
Session 1 - Chair: Mark Searcy, University of East Anglia
11.00	Chris Murray, Astex From fragment to clinic - the discovery of the hsp90 inhibitor, AT13387.
11.45	George Muller, Celgene The discovery of apremilast.
12.30	Lunch (Including SMR AGM 13.10-13.30)
Session 2 - Chair: Diane Coe, GSK
13.30	David Fox, Pfizer The discovery of a second generation long-acting PDE5 inhibitor.
14.15	Simon Hodgson, GSK The discovery of a dual H1/H3 antagonist for allergic rhinitis.
15.00	Tea
Session 3 - Chair: David Fox, Pfizer
15.30	Karl Gibson, Pfizer The discovery of a progesterone receptor antagonist for endometriosis.
16.15	Mairi Gibson, GSK Second generation EP1 antagonists for the treatment of pain.
17.00	Close